The estimated Net Worth of Lucinda H Stebbins is at least 42.5 千$ dollars as of 19 February 2021. Ms. Stebbins owns over 750 units of abrdn Healthcare Opportunities Fund stock worth over 16,298$ and over the last 18 years she sold THQ stock worth over 26,240$. In addition, she makes 0$ as Independent Trustees at abrdn Healthcare Opportunities Fund.
Lucinda has made over 11 trades of the abrdn Healthcare Opportunities Fund stock since 2006, according to the Form 4 filled with the SEC. Most recently she bought 750 units of THQ stock worth 12,600$ on 19 February 2021.
The largest trade she's ever made was buying 3,000 units of abrdn Healthcare Opportunities Fund stock on 9 February 2007 worth over 44,940$. On average, Lucinda trades about 1,289 units every 369 days since 2006. As of 19 February 2021 she still owns at least 750 units of abrdn Healthcare Opportunities Fund stock.
You can see the complete history of Ms. Stebbins stock trades at the bottom of the page.
Lucinda H. Stebbins CPA serves as Independent Trustees of the Company. She brings to each Fund over thirty years experience working in the fund industry, providing valuable perspectives on a variety of technical and industry matters. She serves on the Audit Committee and as Chairman of the Governance and Nominating Committee of each Fund. She started her career with the investment management firm of Scudder, Stevens and Clark, which was later merged into the U.S. operations of Zurich Financial Services, and then finally acquired by Deutsche Bank. She served as a Senior Vice President at Scudder Investments and subsequently as a Director at Deutsche Asset Management and was an officer of approximately 200 funds in these complexes. Ms. Stebbins' expertise is in the accounting, tax, and regulatory sides of the fund business, and she continued through 2015 to act as an independent consultant to the fund industry. Prior to joining Scudder, she was a Senior Manager at Price Waterhouse and is a member of the Massachusetts and Florida Societies of CPAs. She also serves on the Board of Solstice Home Care, Inc., Bald Peak Colony Club and the Pointe at Pelican Bay, served on the Board of Bald Peak Land Company and has been on a number of non-profit Boards. She holds an MBA degree from Babson College and a BA in economics from Wellesley College.
Lucinda Stebbins is 74, she's been the Independent Trustees of abrdn Healthcare Opportunities Fund since 2014. There are no older and 6 younger executives at abrdn Healthcare Opportunities Fund.
Lucinda's mailing address filed with the SEC is C/O TEKLA WORLD HEALTHCARE FUND, 100 FEDERAL STREET, 19TH FLOOR, BOSTON, MA, 02110.
Over the last 10 years, insiders at abrdn Healthcare Opportunities Fund have traded over 0$ worth of abrdn Healthcare Opportunities Fund stock and bought 44,516 units worth 798,865$ . The most active insiders traders include Daniel R Omstead、Jeffrey Allen Bailey、Michael W Bonney. On average, abrdn Healthcare Opportunities Fund executives and independent directors trade stock every 214 days with the average trade being worth of 56,911$. The most recent stock trade was executed by Rose Di Martino on 16 July 2024, trading 1,000 units of THQ stock currently worth 21,300$.
tekla life sciences investors is a closed-ended equity mutual fund launched and managed by tekla capital management llc. the fund invests in public equity markets across the globe. it seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. the fund primarily invests in growth stocks of small cap companies. it employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. the fund benchmarks the performance of its portfolio against the nasdaq biotech index and the s&p 500 index. it was form
abrdn Healthcare Opportunities Fund executives and other stock owners filed with the SEC include: